Ginkgo Bioworks Holdings (DNA) EPS (Basic) (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) reported EPS (Basic) of -$1.28 for Q1 2026, up 23.81% on a YoY basis from -$1.03 in Q1 2025, and up 9.86% quarter-over-quarter from -$1.42 in Q4 2025.
Ginkgo Bioworks Holdings (DNA) EPS (Basic) (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings has reported EPS (Basic) for 7 years, with the latest figure at -$1.28 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 23.81% year-over-year to -$1.28; the trailing twelve-month figure through Mar 2026 stood at -$5.25 (up 41.34% YoY), and the FY2025 full-year result was -$5.64, up 46.49% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.28, up from -$1.42 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.09 in Q2 2023, with the low at -$48.96 in Q4 2022.
- Historically, EPS (Basic) has averaged -$4.61 across 5 years, with a median of -$1.42 in 2025.
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 91.26% — and 2024, when it sank 4600.0%.
- Ginkgo Bioworks Holdings' EPS (Basic) stood at -$48.96 in 2022, then soared by 91.26% to -$4.28 in 2023, then surged by 54.21% to -$1.96 in 2024, then advanced by 27.55% to -$1.42 in 2025, then rose by 9.86% to -$1.28 in 2026.
- The last three EPS (Basic) figures came in at -$1.28 (Q1 2026), -$1.42 (Q4 2025), and -$1.45 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn | -1.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.28 |
| Dec 31, 2025 | -1.42 |
| Sep 30, 2025 | -1.45 |
| Jun 30, 2025 | -1.10 |
| Mar 31, 2025 | -1.68 |
| Dec 31, 2024 | -1.96 |
| Sep 30, 2024 | -1.08 |
| Jun 30, 2024 | -4.23 |
| Mar 31, 2024 | -3.31 |
| Dec 31, 2023 | -4.28 |
| Sep 30, 2023 | -6.21 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | -0.11 |
| Dec 31, 2022 | -48.96 |
| Sep 30, 2022 | -0.41 |
| Jun 30, 2022 | -0.41 |
| Mar 31, 2022 | -0.37 |
| Dec 31, 2021 | -1.17 |
| Sep 30, 2021 | -0.08 |
| Jun 30, 2021 | -0.04 |